E-health and People Living With Major Neurocognitive Disorder - CARE© and ESOGER© Applications

NACompletedINTERVENTIONAL
Enrollment

115

Participants

Timeline

Start Date

December 1, 2022

Primary Completion Date

September 29, 2023

Study Completion Date

September 29, 2023

Conditions
Major Neurocognitive DisorderFrailty
Interventions
OTHER

Recommendations and reorientation towards healthcare resources

"Phase 1~* After completing the CARE© questionnaire, participants will be given recommendations.~* After the ESOGER© assessment, the participants will be contacted by the Red Cross who will set up the necessary interventions. They will be informed of the results of the assessments made.~Phase 2~* After completing the CARE© questionnaire, participants will be given recommendations.~* If their health status is judged fragile by the CARE© score, and after the ESOGER© assessment, the participants will be contacted by the Red Cross who will set up the necessary interventions. They will be informed of the results of the assessments.~For both phases, after 3 (6) months, the participants of the Control group will benefit from the recommendations following the CARE© assessment done at M3 (M6), and if necessary from the ESOGER© assessment and the Red Cross intervention. Throughout the study, they will continue to receive their conventional care."

Trial Locations (1)

H3W 1W5

CRIUGM, Montreal

All Listed Sponsors
lead

Centre integre universitaire de sante et de services sociaux du Centre-Sud-de-l'Île-de-Montréal

OTHER_GOV